Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer.

Reyes ME, de La Fuente M, Hermoso M, Ili CG, Brebi P.

Open source

DOI: 10.3389/fimmu.2020.00901
Published: 2020-05-15
Container: Front Immunol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2020.00901,
  title = {Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer.},
  author = {Reyes ME and  de La Fuente M and  Hermoso M and  Ili CG and  Brebi P.},
  year = {2020},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2020.00901},
  url = {https://doi.org/10.3389/fimmu.2020.00901}
}

RIS

TY  - JOUR
TI  - Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer.
AU  - Reyes ME
AU  -  de La Fuente M
AU  -  Hermoso M
AU  -  Ili CG
AU  -  Brebi P.
PY  - 2020
JO  - Front Immunol
DO  - 10.3389/fimmu.2020.00901
UR  - https://doi.org/10.3389/fimmu.2020.00901
ER  -

APA

ME, R., M, D. L. F., M, H., CG, I., & P., B. (2020). Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer.. Front Immunol. https://doi.org/10.3389/fimmu.2020.00901

Source records

europe-pmc · retrieved 2026-09-27T08:33:44.593Z
doaj · retrieved 2026-09-27T08:33:44.605Z